Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - INTEREST INCOME & EXPENSE
Interest Income & Expense EBS - Emergent BioSolutions Inc.
87.9 M
LAST VALUE
59.62%
2 YEAR CAGR
54.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR